Top Markets
#1 Ontology Gas Ontology Gas +26.68%
#2 Verus Coin Verus Coin +22.51%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +17.69%
#5 Status Status +17.53%
#6 Geodnet Geodnet +14.38%
#7 Derive Derive +12.51%
#8 Curve DAO Curve DAO +11.86%
#9 The Black Bull The Black Bull +10.06%
#10 Anvil Anvil +9.81%
Coin of the day
Ontology Gas Ontology Gas
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rang in Aktien #25502
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aktienkurs
$1.34
Zuletzt synchronisiert: 2024-02-14
Marktkapitalisierung
$48.96M
Veränderung (1 Tag)
-12.94%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Promore Pharma AB (publ) (PROMO)
Dividendenrendite (TTM) von Promore Pharma AB (publ) (Aktienkürzel: PROMO) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Promore Pharma AB (publ) (PROMO) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US